These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1555878)

  • 21. [The influence of hyperlipidemia on pharmacokinetics of free phenytoin].
    Dutkiewicz G; Wójcicki J; Gawrońska-Szklarz B
    Neurol Neurochir Pol; 1995; 29(2):203-11. PubMed ID: 7651592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenytoin and enteral feeding.
    Mohler PA
    JPEN J Parenter Enteral Nutr; 1992; 16(1):95-6. PubMed ID: 1738230
    [No Abstract]   [Full Text] [Related]  

  • 23. Population pharmacokinetics of phenytoin in critically ill children.
    Hennig S; Norris R; Tu Q; van Breda K; Riney K; Foster K; Lister B; Charles B
    J Clin Pharmacol; 2015 Mar; 55(3):355-64. PubMed ID: 25331445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacotherapy in chronic kidney failure].
    Rahn KH
    Verh Dtsch Ges Inn Med; 1974; 80():628-34. PubMed ID: 4616503
    [No Abstract]   [Full Text] [Related]  

  • 25. [Phenytoin--blood levels and clinical aspects].
    Strandfjord RE; Johannessen SI
    Tidsskr Nor Laegeforen; 1973 Feb; 93(6):395-8. PubMed ID: 4698026
    [No Abstract]   [Full Text] [Related]  

  • 26. Intrasubject reproducibility of oral phenytoin pharmacokinetics.
    Lai ML; Lin MS; Huang JD; Hsieh YY
    Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1086-92. PubMed ID: 3235968
    [No Abstract]   [Full Text] [Related]  

  • 27. Phenytoin-enteral feeding interaction.
    Haley CJ; Nelson J
    DICP; 1989 Oct; 23(10):796-8. PubMed ID: 2510408
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic drug monitoring of phenytoin. Rationale and current status.
    Levine M; Chang T
    Clin Pharmacokinet; 1990 Nov; 19(5):341-58. PubMed ID: 2268985
    [No Abstract]   [Full Text] [Related]  

  • 29. [Phenytoin and phenytoin derivatives for local administration].
    Fürst W; Wildner R
    Pharmazie; 1991 Jun; 46(6):424-6. PubMed ID: 1763120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenytoin suppositories and echinacea.
    Kaatz B
    S D J Med; 1997 Sep; 50(9):335. PubMed ID: 9314727
    [No Abstract]   [Full Text] [Related]  

  • 31. Applicability of phenytoin predictive formulas to long-term-care facility residents.
    Drinka PJ; Miller J; Voeks SK
    Clin Pharm; 1988 Jul; 7(7):497-8. PubMed ID: 3138061
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of the emulsion sign in phenytoin bioavailability.
    Savio EO; Fagiolino P; Jelen M; León AS
    Boll Chim Farm; 1994 Apr; 133(4):239-45. PubMed ID: 8068235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoxetine inhibition of phenytoin metabolism.
    Shader RI; Greenblatt DJ; von Moltke LL
    J Clin Psychopharmacol; 1994 Dec; 14(6):375-6. PubMed ID: 7884016
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenytoin and plasmapheresis: importance of sampling times and impact of obesity.
    Olsen KM; Marx MA; Monaghan MS; Barnes E; Ackerman BH; Pappas AA
    Ther Drug Monit; 1994 Dec; 16(6):624-8. PubMed ID: 7878706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic drug monitoring of phenytoin in critically ill patients.
    von Winckelmann SL; Spriet I; Willems L
    Pharmacotherapy; 2008 Nov; 28(11):1391-400. PubMed ID: 18956999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phenytoin].
    Blumenberg D
    Krankenpfl J; 1989 Dec; 27(12):19-21. PubMed ID: 2615321
    [No Abstract]   [Full Text] [Related]  

  • 37. Dosing and therapeutic monitoring of phenytoin in young adults after neurotrauma: are current practices relevant?
    Frend V; Chetty M
    Clin Neuropharmacol; 2007; 30(6):362-9. PubMed ID: 18090462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes associated with brand-to-generic phenytoin interchange.
    Kinikar SA; Delate T; Menaker-Wiener CM; Bentley WH
    Ann Pharmacother; 2012 May; 46(5):650-8. PubMed ID: 22550275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin.
    Kim YC; Kang HE; Lee MG
    Biopharm Drug Dispos; 2008 Jan; 29(1):51-61. PubMed ID: 18022993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of hyperlipidemia on pharmacokinetics of free phenytoin].
    Dudkiewicz G; Wójcik J; Gawrońska-Szklarz B
    Neurol Neurochir Pol; 1994; 28(6):845-52. PubMed ID: 7870258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.